Home
CUE
CUE News

Latest Cue Biopharma Inc. (CUE) News on November 21, 2025

MT Newswires

8 days ago

Cue Biopharma Enters License Deal With ImmunoScape for Next-Generation Cell Therapy for Solid Tumors

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

Business Wire

8 days ago

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates

Zacks

8 days ago

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Lags Revenue Estimates

Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

9 days ago

Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates

Zacks

13 days ago

CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates

Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates

Zacks

14 days ago

Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates

Wall Street says tokenization will change global markets. Gold is next.

Yahoo Finance

20 days ago

Wall Street says tokenization will change global markets. Gold is next.

US negotiating power is strong across the globe, except in China

Yahoo Finance Video

20 days ago

US negotiating power is strong across the globe, except in China

DeepSeek, Qwen AI Besting ChatGPT, Grok, Gemini In AI Crypto Trading Challenge

Benzinga

20 days ago

DeepSeek, Qwen AI Besting ChatGPT, Grok, Gemini In AI Crypto Trading Challenge

Furloughed federal workers face delays getting unemployment pay during shutdown

Associated Press Finance

20 days ago

Furloughed federal workers face delays getting unemployment pay during shutdown

Veralto Corporation (NYSE:VLTO) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Simply Wall St.

20 days ago

Veralto Corporation (NYSE:VLTO) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

The No. 1 Reason New Businesses Fail, According to a Shark Tank Investor

GOBankingRates

20 days ago

The No. 1 Reason New Businesses Fail, According to a Shark Tank Investor

Ryerson Holding (NYSE:RYI) Is Due To Pay A Dividend Of $0.1875

Simply Wall St.

20 days ago

Ryerson Holding (NYSE:RYI) Is Due To Pay A Dividend Of $0.1875

2 Big Tech Stocks Just Announced Stock Splits. Here's What You Need to Know.

Motley Fool

20 days ago

2 Big Tech Stocks Just Announced Stock Splits. Here's What You Need to Know.

Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates

Zacks

22 days ago

Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates

MT Newswires

5 months ago

Cue Biopharma Receives FDA Feedback for Trial Design of Drug Candidate to Treat Autoimmune Diseases

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

GlobeNewswire

5 months ago

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

MT Newswires

5 months ago

Cue Biopharma CFO Kerri-Ann Millar to Depart

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Zacks

6 months ago

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire

6 months ago

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

GlobeNewswire

6 months ago

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

GlobeNewswire

7 months ago

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

Earnings Preview: Opus Genetics, Inc. (IRD) Q1 Earnings Expected to Decline

Zacks

7 months ago

Earnings Preview: Opus Genetics, Inc. (IRD) Q1 Earnings Expected to Decline

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Zacks

7 months ago

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know

Boehringer, Oxford University and Cumulus to explore brain activity in BPD

Pharmaceutical Technology

7 months ago

Boehringer, Oxford University and Cumulus to explore brain activity in BPD

Boehringer and Cue Biopharma to develop autoimmune therapies

Pharmaceutical Technology

7 months ago

Boehringer and Cue Biopharma to develop autoimmune therapies

MT Newswires

7 months ago

Cue Biopharma Prices $20 Million Public Offering of Stock, Warrants

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering

GlobeNewswire

7 months ago

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering

MT Newswires

7 months ago

Cue Biopharma Starts Underwritten Equity Offering

Cue Biopharma Announces Proposed Public Offering

GlobeNewswire

7 months ago

Cue Biopharma Announces Proposed Public Offering

Cue Biopharma to Host Business Update Call and Webcast

GlobeNewswire

7 months ago

Cue Biopharma to Host Business Update Call and Webcast

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

GlobeNewswire

7 months ago

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

Cue Biopharma Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

8 months ago

Cue Biopharma Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates

Zacks

8 months ago

Cue Biopharma, Inc. (CUE) Reports Q4 Loss, Misses Revenue Estimates

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

GlobeNewswire

8 months ago

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?

Zacks

8 months ago

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength?

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire

a year ago

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations

MT Newswires

a year ago

Jefferies Cuts Price Target on Cue Biopharma to $4 From $6, Maintains Buy Rating

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a year ago

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma Announces Strategic Organizational Transition

GlobeNewswire

a year ago

Cue Biopharma Announces Strategic Organizational Transition

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

GlobeNewswire

a year ago

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

GlobeNewswire

a year ago

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89%

Simply Wall St.

a year ago

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89%

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

GlobeNewswire

a year ago

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

MT Newswires

a year ago

Cue Biopharma Prices $12 Million Offering

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

GlobeNewswire

a year ago

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

Cue Biopharma Announces Proposed Public Offering

GlobeNewswire

a year ago

Cue Biopharma Announces Proposed Public Offering

MT Newswires

a year ago

Cue Biopharma Queues Up Stock Sale

Cue Biopharma Announces Proposed Public Offering

GlobeNewswire

a year ago

Cue Biopharma Announces Proposed Public Offering

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

GlobeNewswire

a year ago

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

GlobeNewswire

a year ago

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

Thomson Reuters StreetEvents

a year ago

Q2 2024 Cue Biopharma Inc Earnings Call

MT Newswires

a year ago

Cue Biopharma Q2 Net Loss Narrows, Revenue Rises

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Zacks

a year ago

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma to Host Business Update Call and Webcast

GlobeNewswire

a year ago

Cue Biopharma to Host Business Update Call and Webcast

Cue Biopharma downsizes to focus on autoimmune pipeline

Pharmaceutical Technology

a year ago

Cue Biopharma downsizes to focus on autoimmune pipeline

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

GlobeNewswire

a year ago

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

Zacks

a year ago

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

GlobeNewswire

a year ago

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

GlobeNewswire

a year ago

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

Cue Biopharma First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

2 years ago

Cue Biopharma First Quarter 2024 Earnings: Beats Expectations

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

2 years ago

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

GlobeNewswire

2 years ago

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

GlobeNewswire

2 years ago

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks

Zacks

2 years ago

Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

2 years ago

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now

Zacks

2 years ago

Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Cue Biopharma Inc Earnings Call

GuruFocus.com

2 years ago

Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

GlobeNewswire

2 years ago

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Cue Biopharma to Host Business Update Call and Webcast

GlobeNewswire

2 years ago

Cue Biopharma to Host Business Update Call and Webcast

Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline

Zacks

2 years ago

Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

GlobeNewswire

2 years ago

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?

Zacks

2 years ago

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

2 years ago

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

Zacks

2 years ago

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

What To Expect From Magnachip’s (MX) Q4 Earnings

StockStory

2 years ago

What To Expect From Magnachip’s (MX) Q4 Earnings

Red Robin (RRGB) Rises Higher Than Market: Key Facts

Zacks

2 years ago

Red Robin (RRGB) Rises Higher Than Market: Key Facts

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

PR Newswire

2 years ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?

Insider Monkey

2 years ago

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 years ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

PR Newswire

2 years ago

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

PCB Bancorp Reports Earnings of $5.9 million for Q4 2023 and $30.7 million for 2023

Business Wire

2 years ago

PCB Bancorp Reports Earnings of $5.9 million for Q4 2023 and $30.7 million for 2023

Grindrod Shipping Holdings Ltd. Announces Ship Sales

GlobeNewswire

2 years ago

Grindrod Shipping Holdings Ltd. Announces Ship Sales

Murphy Oil (MUR) Lags Q4 Earnings Estimates

Zacks

2 years ago

Murphy Oil (MUR) Lags Q4 Earnings Estimates

Owning 70% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's future

Simply Wall St.

2 years ago

Owning 70% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's future

AI Shows Signs of Maturity, Expansion in Brazil

Business Wire

2 years ago

AI Shows Signs of Maturity, Expansion in Brazil

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts

Zacks

2 years ago

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript

Comtech (CMTL) Soars 15.3%: Is Further Upside Left in the Stock?

Zacks

2 years ago

Comtech (CMTL) Soars 15.3%: Is Further Upside Left in the Stock?

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?

Simply Wall St.

2 years ago

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?

Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know

Zacks

2 years ago

Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

GlobeNewswire

2 years ago

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

With 52% institutional ownership, American Public Education, Inc. (NASDAQ:APEI) is a favorite amongst the big guns

Simply Wall St.

2 years ago

With 52% institutional ownership, American Public Education, Inc. (NASDAQ:APEI) is a favorite amongst the big guns

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

GlobeNewswire

2 years ago

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

Share on Social Networks: